Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint.
This parameter reviews the current state of the prevention and management of child and adolescent aggressive behavior in psychiatric institutions, with particular reference to the indications and use of seclusion and restraint. It also presents guidelines that have been developed in response to professional, regulatory, and public concern about the use of restrictive interventions with aggressive patients with regard to personal safety and patient rights. The literature on the use of seclusion, physical restraint, mechanical restraint, and chemical restraint is reviewed, and procedures for carrying out each of these interventions are described. Clinical and regulatory agency perspectives on these interventions are presented. Effectiveness, indications, contraindications, complications, and adverse effects of seclusion and restraint procedures are addressed. Interventions are presented to provide more opportunities to promote patient independence and satisfaction with treatment while diminishing the necessity of using restrictive procedures.
Masters
Kim J
KJ
Bellonci
Christopher
C
Bernet
William
W
Arnold
Valerie
V
Beitchman
Joseph
J
Benson
R Scott
RS
Bukstein
Oscar
O
Kinlan
Joan
J
McClellan
Jon
J
Rue
David
D
Shaw
Jon A
JA
Stock
Saundra
S
D000293:Adolescent; D000374:Aggression / Q000187:drug effects / Q000523:psychology*; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy* / Q000517:prevention & control* / Q000523:psychology; D003419:Crisis Intervention; D006778:Hospitals, Psychiatric / Q000331:legislation & jurisprudence; D006801:Humans; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012149:Restraint, Physical / Q000331:legislation & jurisprudence / Q000523:psychology; D012934:Social Isolation / Q000523:psychology; D014481:United States
D011619:Psychotropic Drugs